Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Smart contact lens-trained digital twin for device-free personalized uric acid prediction.

Science advances·2026
Same author

Adoptive T-cell therapies in the clinic.

Bioengineering & translational medicine·2026
Same author

Efficient Direct Recycling of Spent Batteries: Integrated Lithiation and Delamination.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Engineering macrophages for cancer immunotherapy: emerging insights and therapeutic potential.

npj biomedical innovations·2026
Same author

In-the-Clinic series: A 10 year journey.

Bioengineering & translational medicine·2026
Same author

Posture Tracking of Active Capsule Endoscopes Integrated with Magnetic Actuation Using Hall-Effect Sensors.

Micromachines·2026

Related Experiment Video

Updated: Jun 25, 2025

A Simple and Efficient Method for Testing Immunomodulatory Agents for Generation of Tolerogenic Dendritic Cells from Human CD14+ Monocytes
11:34

A Simple and Efficient Method for Testing Immunomodulatory Agents for Generation of Tolerogenic Dendritic Cells from Human CD14+ Monocytes

Published on: April 11, 2025

214

Dendritic Cell Immune Modulation via Polyphenol Membrane Coatings.

Morgan E Janes1,2,3, Kyung Soo Park2,3, Alexander P Gottlieb2,3

  • 1Harvard-MIT Division of Health Sciences & Technology, Cambridge, Massachusetts 02139, United States.

ACS Applied Materials & Interfaces
|May 23, 2024
PubMed
Summary

Researchers developed a new method, META (membrane engineering using tannic acid), enabling cellular hitchhiking for dendritic cells (DCs). This breakthrough allows targeted drug delivery to DCs, advancing immune cell therapies for various diseases.

Keywords:
cell therapydendritic cellsimmunotherapyphenolic networkvaccines

More Related Videos

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy
08:40

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy

Published on: August 1, 2013

18.3K
Author Spotlight: Dendritic Cells Maturation Using Sialidases-Based Enzymatic Treatment of the Cell Surface
13:36

Author Spotlight: Dendritic Cells Maturation Using Sialidases-Based Enzymatic Treatment of the Cell Surface

Published on: October 20, 2023

3.5K

Related Experiment Videos

Last Updated: Jun 25, 2025

A Simple and Efficient Method for Testing Immunomodulatory Agents for Generation of Tolerogenic Dendritic Cells from Human CD14+ Monocytes
11:34

A Simple and Efficient Method for Testing Immunomodulatory Agents for Generation of Tolerogenic Dendritic Cells from Human CD14+ Monocytes

Published on: April 11, 2025

214
Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy
08:40

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy

Published on: August 1, 2013

18.3K
Author Spotlight: Dendritic Cells Maturation Using Sialidases-Based Enzymatic Treatment of the Cell Surface
13:36

Author Spotlight: Dendritic Cells Maturation Using Sialidases-Based Enzymatic Treatment of the Cell Surface

Published on: October 20, 2023

3.5K

Area of Science:

  • Immunology
  • Biotechnology
  • Drug Delivery

Background:

  • Cellular hitchhiking, using nanoparticles to control transferred immune cells via local drug delivery, has advanced T cell therapies.
  • Engineering phagocytic cells like dendritic cells (DCs) for hitchhiking is challenging due to their phagocytic capacity, limiting DC vaccine potential.
  • Current hitchhiking methods are incompatible with DCs, hindering the development of combination drug delivery strategies to manipulate DC function.

Purpose of the Study:

  • To develop a novel method for enabling cellular hitchhiking in dendritic cells (DCs) for targeted drug delivery.
  • To create a platform for local drug delivery to DCs, enhancing their therapeutic potential in various diseases.
  • To demonstrate the flexibility of the approach for modulating DC phenotype and function for applications in cancer and autoimmune diseases.

Main Methods:

  • Developed META (membrane engineering using tannic acid), a method utilizing tannic acid to assemble protein drug cargoes on the DC cell membrane.
  • Optimized META formulations for incorporating and releasing protein cargoes with diverse physical properties.
  • Validated META's ability to preserve DC viability and critical functions, including migration.

Main Results:

  • Successfully enabled cellular hitchhiking in DCs for the first time using the META approach.
  • Demonstrated that META can incorporate and release various protein cargoes, alone or in combination, while maintaining DC function.
  • Showcased that META-loaded DCs with pro- or anti-inflammatory cargoes can alter carrier cell phenotype, indicating therapeutic potential.

Conclusions:

  • META provides a novel platform for the first time to achieve cellular hitchhiking in dendritic cells (DCs).
  • This approach facilitates local drug delivery to DCs, enabling modulation of their phenotype and function.
  • META represents a significant advancement for controlling phagocytic immune cells, paving the way for improved DC-based therapies.